A spectrum of pathological conditions like cancer is linked with the deregulation of different RTKs, such as EGFR, platelet-derived growth factor receptor (PDGFR), hepatocyte growth factor receptor (HGFR), and IGF-1R [62]. The gene discussed is MET; the disease is cancer.